D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 61 Citations 15,351 151 World Ranking 1917 National Ranking 159

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Gene

Thomas S. Harrison focuses on Immunology, Meningitis, Internal medicine, Cryptococcosis and Fluconazole. The various areas that he examines in his Immunology study include Cryptococcus, Urine and Genus Candida. His Meningitis research incorporates elements of Incidence, Mortality rate, Sida, Retrospective cohort study and Prospective cohort study.

His Internal medicine research includes themes of Gastroenterology, Amphotericin B and Surgery. Thomas S. Harrison combines subjects such as Immune system, Immunity, Mycosis and Cryptococcus neoformans with his study of Cryptococcosis. His Fluconazole research includes elements of Pharmacotherapy and Immune reconstitution inflammatory syndrome.

His most cited work include:

  • Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. (1551 citations)
  • Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial (366 citations)
  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)

What are the main themes of his work throughout his whole career to date?

Thomas S. Harrison mostly deals with Meningitis, Internal medicine, Immunology, Cryptococcosis and Fluconazole. His Meningitis study incorporates themes from Pharmacokinetics, Incidence, Virology, Cryptococcal meningitis and Asymptomatic. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Surgery and Tuberculosis.

His Immunology study combines topics from a wide range of disciplines, such as Mortality rate, Cryptococcus, Immune reconstitution inflammatory syndrome and Cerebrospinal fluid. Thomas S. Harrison usually deals with Cryptococcosis and limits it to topics linked to Acquired immunodeficiency syndrome and Health care. His biological study deals with issues like Amphotericin B, which deal with fields such as First episode, Pharmacotherapy and Clinical trial.

He most often published in these fields:

  • Meningitis (41.34%)
  • Internal medicine (34.08%)
  • Immunology (37.43%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (34.08%)
  • Cryptococcal meningitis (26.26%)
  • Meningitis (41.34%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Cryptococcal meningitis, Meningitis, Fluconazole and Flucytosine. His biological study spans a wide range of topics, including Gastroenterology and Tuberculosis. His work deals with themes such as Subclinical infection and Immunology, Cryptococcosis, which intersect with Meningitis.

In his research, Combination therapy is intimately related to Cryptococcus, which falls under the overarching field of Immunology. His Fluconazole research is multidisciplinary, incorporating elements of Asymptomatic and Incidence. His studies deal with areas such as Public sector and Cryptococcus neoformans as well as Flucytosine.

Between 2018 and 2021, his most popular works were:

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium (285 citations)
  • Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial (52 citations)
  • Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis (45 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Gene

His primary areas of investigation include Internal medicine, Fluconazole, Meningitis, Flucytosine and Amphotericin B. His research links Azithromycin with Internal medicine. His study in Fluconazole is interdisciplinary in nature, drawing from both Cryptococcus and Combination therapy.

His studies in Meningitis integrate themes in fields like Asymptomatic and Incidence. His work carried out in the field of Flucytosine brings together such families of science as Pediatrics and Cryptococcus neoformans. He has included themes like Cryptococcal meningitis and Confidence interval in his Amphotericin B study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

John R. Perfect;William E. Dismukes;Francoise Dromer;David L. Goldman.
Clinical Infectious Diseases (2010)

2660 Citations

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach.
Clinical Infectious Diseases (2020)

1098 Citations

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

Annemarie E Brouwer;Adul Rajanuwong;Wirongrong Chierakul;George E Griffin.
The Lancet (2004)

559 Citations

High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis

Amina Jindani;Thomas S. Harrison;Andrew J. Nunn;Patrick P.J. Phillips.
The New England Journal of Medicine (2014)

433 Citations

Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole

Tihana Bicanic;Graeme Meintjes;Robin Wood;Madeleine Hayes.
Clinical Infectious Diseases (2007)

362 Citations

Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa

Joseph N Jarvis;Stephen D Lawn;Monica Vogt;Nonzwakazi Bangani.
Clinical Infectious Diseases (2009)

347 Citations

Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes

Joseph N. Jarvis;Tihana Bicanic;Angela Loyse;Daniel Namarika.
Clinical Infectious Diseases (2014)

332 Citations

Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.

Peter R. Williamson;Joseph N. Jarvis;Anil A. Panackal;Matthew C. Fisher.
Nature Reviews Neurology (2017)

331 Citations

HIV-associated cryptococcal meningitis

Joseph N Jarvis;Thomas S Harrison.
AIDS (2007)

321 Citations

Evaluation of a Novel Point-of-Care Cryptococcal Antigen Test on Serum, Plasma, and Urine From Patients With HIV-Associated Cryptococcal Meningitis

JN Jarvis;A Percival;S Bauman;J Pelfrey.
Clinical Infectious Diseases (2011)

319 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas S. Harrison

John R. Perfect

John R. Perfect

Duke University

Publications: 118

Arturo Casadevall

Arturo Casadevall

Johns Hopkins University

Publications: 92

Graeme Meintjes

Graeme Meintjes

University of Cape Town

Publications: 75

Peter R. Williamson

Peter R. Williamson

National Institutes of Health

Publications: 59

Joseph Heitman

Joseph Heitman

Duke University

Publications: 58

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 56

Wieland Meyer

Wieland Meyer

University of Sydney

Publications: 55

Ferry Hagen

Ferry Hagen

Utrecht University

Publications: 53

David W. Denning

David W. Denning

University of Manchester

Publications: 52

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 51

Marcio L. Rodrigues

Marcio L. Rodrigues

Federal University of Rio de Janeiro

Publications: 49

Teun Boekhout

Teun Boekhout

University of Amsterdam

Publications: 48

Anne Puel

Anne Puel

Université Paris Cité

Publications: 47

Tom Chiller

Tom Chiller

Centers for Disease Control and Prevention

Publications: 45

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 41

Robin C. May

Robin C. May

University of Birmingham

Publications: 39

Trending Scientists

Tim Harris

Tim Harris

Oracle (United States)

Kikuo Kishimoto

Kikuo Kishimoto

Tokyo Institute of Technology

Zümriye Aksu

Zümriye Aksu

Hacettepe University

Roberta O. Day

Roberta O. Day

University of Massachusetts Amherst

Marina García-Llorente

Marina García-Llorente

Autonomous University of Madrid

Robin W. Baird

Robin W. Baird

Cascadia Research Collective

Kyle E. Harms

Kyle E. Harms

Louisiana State University

David W. Hagstrum

David W. Hagstrum

Kansas State University

Frédéric Relaix

Frédéric Relaix

Paris-Est Créteil University

John H. Fingert

John H. Fingert

University of Iowa

Tapas K. Hazra

Tapas K. Hazra

The University of Texas Medical Branch at Galveston

Fernando Roberto Martins

Fernando Roberto Martins

State University of Campinas

Craig L. Slingluff

Craig L. Slingluff

University of Virginia

Tinca J. C. Polderman

Tinca J. C. Polderman

Vrije Universiteit Amsterdam

Stephen T. Higgins

Stephen T. Higgins

University of Vermont

Randolph M. Siverson

Randolph M. Siverson

University of California, Davis

Something went wrong. Please try again later.